化学
立体化学
嘧啶
药品
结构-活动关系
作用机理
药物发现
铅化合物
血浆蛋白结合
阻塞(统计)
组合化学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
拟肽
残留物(化学)
行动方式
冠状病毒
生物化学
结构母题
计算生物学
抗病毒药物
结合位点
2019年冠状病毒病(COVID-19)
鉴定(生物学)
效力
蛋白质-蛋白质相互作用
二硫键
数量结构-活动关系
体外
蛋白质结构
生物活性
化学合成
2019-20冠状病毒爆发
病毒蛋白
作者
Yue Gong,Zhihui Yu,Runze Meng,Xican Ma,Jianrui Li,Qionglu Duan,Hongxuan Li,Jingyang Zhu,Yanhong Li,Xinyi Li,Yanan Ni,Yinghong Li,Yonghua Liu,Zonggen Peng,Danqing Song
标识
DOI:10.1021/acs.jmedchem.6c02138
摘要
Abstract The pyrimidine nucleus serves as a key structural motif in drug discovery. Using compound 1 as the lead, we synthesized a series of new aminopyrimidine analogues and assessed their antiviral activity against HCoV-OC43. Among them, compound 13h showed exceptional potency, with an EC50 of 0.12 μM, an SI over 800, and a good safety profile. Systematic mechanistic studies revealed that compound 13h specifically binds to the V201 residue of the M structural protein, disrupting the critical M−N protein interaction required for viral assembly. The V201 site is located precisely at the M−N interaction interface, which accounts for the high potency and safety of 13h. Conclusively, we discovered the first small-molecule inhibitor targeting the M−N binding interface. This novel mechanism of action distinguishes it from existing anti-coronavirus drugs and establishes a promising new antiviral strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI